ATE163265T1 - Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten - Google Patents

Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten

Info

Publication number: ATE163265T1
Authority: AT; Austria
Prior art keywords: pct; water; pharmaceutical compositions; compositions containing; assoluble
Prior art date: 1993-09-17

Application number

AT94925394T

Other languages

English (en)

Inventor

Romano Deghenghi

Original Assignee

Romano Deghenghi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-17

Filing date

1994-07-26

Publication date

1998-03-15

1994-07-26 Application filed by Romano Deghenghi filed Critical Romano Deghenghi

1998-03-15 Application granted granted Critical

1998-03-15 Publication of ATE163265T1 publication Critical patent/ATE163265T1/de

Links

159000000007 calcium salts Chemical class 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical class OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 title 1
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
HZEQBCVBILBTEP-ZFINNJDLSA-N estropipate Chemical compound C1CNCCN1.OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 HZEQBCVBILBTEP-ZFINNJDLSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
150000007524 organic acids Chemical class 0.000 abstract 2
-1 bicarbonate compound Chemical class 0.000 abstract 1
229910000020 calcium bicarbonate Inorganic materials 0.000 abstract 1
229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
229950008385 estrone sulphate Drugs 0.000 abstract 1
229940081345 estropipate Drugs 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Inorganic Chemistry (AREA)
Nutrition Science (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

AT94925394T 1993-09-17 1994-07-26 Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten ATE163265T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITMI932014A IT1270831B (it)	1993-09-17	1993-09-17	Composizioni farmaceutiche orali effervescenti contenenti estrone

Publications (1)

Publication Number	Publication Date
ATE163265T1 true ATE163265T1 (de)	1998-03-15

Family

ID=11366921

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94925394T ATE163265T1 (de)	1993-09-17	1994-07-26	Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten

Country Status (12)

Country	Link
US (1)	US5720977A (de)
EP (1)	EP0719148B1 (de)
JP (1)	JPH09502709A (de)
KR (1)	KR100314338B1 (de)
AT (1)	ATE163265T1 (de)
AU (1)	AU7532994A (de)
CA (1)	CA2171829A1 (de)
DE (1)	DE69408579T2 (de)
ES (1)	ES2112555T3 (de)
IL (1)	IL110471A (de)
IT (1)	IT1270831B (de)
WO (1)	WO1995007701A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997004752A1 (en) *	1995-07-26	1997-02-13	Duramed Pharmaceuticals, Inc.	Pharmaceutical compositions of conjugated estrogens and methods for their use
US6726922B1 (en)	1999-06-28	2004-04-27	Minu, L.L.C.	Process and composition for temporarily suppressing pain
EP1210368A2 (de) *	1999-09-08	2002-06-05	Immunex Corporation	Verwendung von semaphorin zur modulierung des zellausflusses
PT1591121E (pt) *	2000-12-14	2009-07-20	Ortho Mcneil Janssen Pharm	Processo para preparar produtos de hormona esteróide compreendendo um agente estabilizante na forma não cristalina
US6630166B1 (en)	2001-02-12	2003-10-07	Watson Pharmaceuticals, Inc.	Compositions for conjugated estrogens and associated methods
US7303763B2 (en) *	2001-02-12	2007-12-04	Watson Laboratories, Inc.	Compositions for conjugated estrogens and associated methods
US20030068356A1 (en)	2001-07-10	2003-04-10	Pather S. Indiran	Sequential drug delivery systems
US20050089502A1 (en) *	2003-08-21	2005-04-28	Todd Schansberg	Effervescent delivery system
EP1853272A1 (de) *	2005-02-03	2007-11-14	Duramed Pharmaceuticals, Inc.	Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
WO2007076144A2 (en) *	2005-12-27	2007-07-05	Duramed Pharmaceuticals, Inc.	Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5004651A (en) *	1989-01-24	1991-04-02	Abbott Laboratories	Stabilizing system for solid dosage forms

1993
- 1993-09-17 IT ITMI932014A patent/IT1270831B/it active IP Right Grant
1994
- 1994-07-26 WO PCT/EP1994/002465 patent/WO1995007701A1/en not_active Ceased
- 1994-07-26 AT AT94925394T patent/ATE163265T1/de not_active IP Right Cessation
- 1994-07-26 DE DE69408579T patent/DE69408579T2/de not_active Expired - Fee Related
- 1994-07-26 CA CA002171829A patent/CA2171829A1/en not_active Abandoned
- 1994-07-26 US US08/592,377 patent/US5720977A/en not_active Expired - Fee Related
- 1994-07-26 EP EP94925394A patent/EP0719148B1/de not_active Expired - Lifetime
- 1994-07-26 ES ES94925394T patent/ES2112555T3/es not_active Expired - Lifetime
- 1994-07-26 KR KR1019960701321A patent/KR100314338B1/ko not_active Expired - Fee Related
- 1994-07-26 JP JP7508930A patent/JPH09502709A/ja not_active Ceased
- 1994-07-26 AU AU75329/94A patent/AU7532994A/en not_active Abandoned
- 1994-07-27 IL IL11047194A patent/IL110471A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO1995007701A1 (en)	1995-03-23
IL110471A (en)	1998-10-30
ES2112555T3 (es)	1998-04-01
JPH09502709A (ja)	1997-03-18
IL110471A0 (en)	1994-10-21
EP0719148A1 (de)	1996-07-03
ITMI932014A0 (it)	1993-09-17
EP0719148B1 (de)	1998-02-18
US5720977A (en)	1998-02-24
CA2171829A1 (en)	1995-03-23
AU7532994A (en)	1995-04-03
DE69408579D1 (de)	1998-03-26
IT1270831B (it)	1997-05-13
KR100314338B1 (ko)	2002-02-28
ITMI932014A1 (it)	1995-03-17
DE69408579T2 (de)	1998-06-18

Similar Documents

Publication	Publication Date	Title
KR960700708A (ko)	1996-02-24	3,4-디아릴크로만을 이용한 뼈 손실의 억제방법(methdos for inhibiting bone loss with 3,4-diarylchroman)
IL115357A (en)	2000-01-31	Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
EA199900075A1 (ru)	1999-06-24	Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
TR200101261T2 (tr)	2002-05-21	Uzun süreli salınımlı ranolazin formülasyonları.
ATE158504T1 (de)	1997-10-15	Brausemischungen enthaltend ibuprofen und verfahren
DE69832710D1 (de)	2006-01-12	Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
GB0031312D0 (en)	2001-02-07	Macrolides
UY24308A1 (es)	1996-08-27	Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
IL108234A0 (en)	1994-04-12	Pharmaceutical composition containing galanthamine
BRPI0410116A (pt)	2006-05-23	tablete de cuidado oral
IS2789B (is)	2012-06-15	Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
ATE163265T1 (de)	1998-03-15	Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten
ATE220321T1 (de)	2002-07-15	Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
HU9400430D0 (en)	1994-05-30	New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
IL109534A0 (en)	1994-08-26	Pour-on formulations containing polymeric material, glycols and glycerides and a process for their preparation
TR200000153T2 (tr)	2000-07-21	İl-5 inhibite eden 6-azaurasil türevleri.
AU666422B2 (en)	1996-02-08	Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds
KR890006236A (ko)	1989-06-12	피페리디노 알칸올-충혈제거제 조합을 위한 약제학적 조성물
SE9301112D0 (sv)	1993-04-02	A new composition
HUT73679A (en)	1996-09-30	N-{[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-n-methylamino}-2-benzothiazolol derivatives class iii. antiarhythmic agents containing the same and process for their preparation
GT199900171A (es)	2001-03-28	Concentrado oral de sertralina.
NO950177L (no)	1995-01-17	Farmakologisk aktive erivater
DE69414396D1 (de)	1998-12-10	Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
AP9801235A0 (en)	1999-11-07	Erythromycin derivatives.
YU81101A (sh)	2004-07-15	Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija

Legal Events

Date	Code	Title	Description
1998-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties